Treatment
Drug clinical trials
We’re tracking 1,302 recruiting studies that include Drug, each written for real people, not researchers, below.
Recruiting studies
- NCT06554288RecruitingPhase 1
Trihexyphenidyl for dystonia in cerebral palsy
This study tests how a medicine called trihexyphenidyl works in children with dystonic cerebral palsy, a condition that causes muscle spasms. Researchers want to learn if a child’s genes affect how the medicine works and how the body processes it.
Kansas City, MissouriAges 5–17 - NCT06565845Recruiting
Comparing treatments for granulomatous lobular mastitis
This study looks at different ways to treat granulomatous lobular mastitis (GLM), a type of breast inflammation that is not an infection. The goal is to find which treatment works best for people with this condition.
Harbin, HeilongjiangAges 15–65 - NCT06572085RecruitingPhase 4
Butylphthalide for brain protection after cardiac arrest
This trial tests a medicine called butylphthalide (NBP) to see if it helps protect the brain after a cardiac arrest. It is for adults who remained unconscious after their heart was restarted.
Beijing, Beijing MunicipalityAges 18–80 - NCT06573489RecruitingPhase 4
Fospropofol for laparoscopic surgery safety study
This trial tests a sedative called fospropofol during laparoscopic abdominal surgery. It aims to see if it's safe and effective for adults with longer operations.
Wuhan, HubeiAges 18–65 - NCT06575478RecruitingPhase 2
Herbal granules for new type 2 diabetes patients
This study tests two herbal granules (Fuling Yunhua and Dihuang Baoyuan) to see if they help control blood sugar in people with type 2 diabetes who have not yet taken diabetes medication. You will be randomly assigned to one of the granules or a placebo for several weeks, and your blood sugar will be monitored closely.
BeijingAges 18–75 - NCT06580860Recruiting
Brain health study for young people with early psychosis
This study looks at brain scans and other health information to understand mental health conditions better. You may be able to join if you are a young adult or teen with early signs of mental health changes.
Changsha, HunanAges 13–35 - NCT06584799RecruitingPhase 3
Medication for pelvic vein disorder symptoms
This trial tests a venoactive drug (a medication that improves vein tone and blood flow) to see if it relieves symptoms like pelvic pain, pain during sex, and discomfort in the lower belly caused by pelvic varicose veins (enlarged veins). It may help people who have these symptoms confirmed by ultrasound.
MoskvaAges 18–45 - NCT06596434RecruitingPhase 2
Testing 4-aminopyridine cream for faster burn healing
This study tests a medicine called 4-aminopyridine (also used for nerve conditions) to see if it helps second-degree burns heal faster. If you have a fresh burn, you might be able to join.
Tucson, ArizonaAges 18 years+ - NCT06599957Recruiting
Light-based drug delivery for sarcoma treatment
This trial tests a new light-based drug delivery system to treat sarcomas. It looks at how well this platform works during surgery or biopsy for patients with soft tissue or bone sarcomas.
Bologna, Emilia-RomagnaAges 2–85 - NCT05730283RecruitingPhase 2
Preventing hearing damage from IV amikacin in NTM patients
This Phase 2 study looks at ways to prevent hearing damage (ototoxicity) in people with NTM lung infection who are treated with IV amikacin. If you qualify, the study may help protect your hearing while you receive a treatment that can sometimes affect hearing.
San Francisco, CaliforniaAges 18–80 - NCT07220538RecruitingPhase 4
Ginkgo biloba for memory problems after a mild stroke
This trial tests whether adding ginkgo biloba extract tablets to standard stroke care helps improve memory and thinking in people who had a mild stroke. You may join if you are 55 or older, had a mild stroke in the last 1 to 2 weeks, and now have some cognitive difficulties.
AnyangAges 55 years+ - NCT07530146RecruitingPhase 3
Sedation Medications for Older ICU Patients on Breathing Machines
This study compares two sedation medications—propofol alone versus propofol combined with ketamine—in older patients in the ICU who are on breathing machines due to infection or lung problems. The goal is to find which combination is safer and works better for keeping patients calm and comfortable.
CairoAges 65 years+ - NCT06604728Recruiting
IV vs. shot biologics for IBD: which works better?
This study compares intravenous (IV) and under-the-skin (subcutaneous) biologic drugs for people with Crohn's disease or ulcerative colitis. It helps doctors understand if switching from the IV form to a shot is as effective and well-tolerated.
RomaAges 18 years+ - NCT06607445Recruiting
Testing a personalized medicine program in Extremadura
This study looks at a program called MedeA that uses your genes to help choose the right medicines for you. If you live in Extremadura and are starting or already on treatment, you may be able to join.
BadajozAges Any age - NCT06612632RecruitingPhase 1/Phase 2
Retrying Immunotherapy for Solid Tumors After First Trial
This trial tests whether giving immunotherapy again can help people with solid tumors who have already tried an experimental treatment in a clinical trial and it stopped working. It looks for patients whose cancer has returned or spread and who can start the new treatment within 12 weeks of their last therapy.
BeijingAges 18 years+ - NCT06615596RecruitingEarly Phase 1
Stopping blood thinners after successful atrial fibrillation ablation
This trial tests whether it is safe to stop taking blood thinners (anticoagulants) after a successful ablation procedure for atrial fibrillation. If you have had no AF for 3 months after your first ablation, you may be able to stop these medications, reducing your risk of bleeding.
Boston, MassachusettsAges 18 years+ - NCT06616584RecruitingPhase 2/Phase 3
Cemiplimab plus standard care for advanced lung cancer after prior treatments
This trial tests whether adding the immunotherapy drug cemiplimab to standard treatment can help people with advanced lung cancer that has already progressed after both platinum chemo and a prior immunotherapy. It is designed for those who responded to their first immunotherapy for at least 12 weeks before the cancer started growing again.
Daphne, AlabamaAges 18 years+ - NCT06617832Recruiting
Evaluating migraine treatment designs
This trial is testing new ways to treat migraine attacks. It is for adults in Denmark who have migraine on a few days each month and have used triptan rescue medicines.
Aarhus CAges 18–65 - NCT06620380RecruitingPhase 2
Testing tumor samples to find the best drug for brain metastases
This trial tests tumor samples from brain metastases to see which drug might work best for you. It aims to guide your next treatment when standard options are limited.
BaselAges 18 years+ - NCT06620562RecruitingPhase 4
Testing a weight loss pill after sleeve gastrectomy surgery
This study tests whether adding a medication (naltrexone/bupropion) to sleeve gastrectomy surgery can improve weight loss. It may be a good fit if you are eligible for a first-time sleeve gastrectomy and meet certain health criteria.
Québec, QuebecAges 18–65 - NCT06621563RecruitingPhase 1
Study of HS-20117 Combination Therapy for Advanced Solid Tumors
This early-phase trial tests a new drug (HS-20117) combined with other drugs for people with advanced solid tumors. It aims to see if the combination is safe and effective, especially for cancers that have not responded to other treatments.
TianjinAges 18–75 - NCT06627309Recruiting
Rapid blood protein response and remission in AL amyloidosis
This trial is for people with AL amyloidosis who are being treated with daratumumab, bortezomib, and dexamethasone. It looks at how quickly a certain blood protein (called dFLC) drops after treatment starts and whether that predicts a complete remission.
Beijing, Beijing MunicipalityAges 18–99 - NCT06630923RecruitingPhase 3
Preventing kidney worsening with IV albumin in heart failure
This trial tests if giving a medicine called albumin through a vein can help prevent kidney function from getting worse in people hospitalized with worsening heart failure and liver problems. It may be an option if other treatments haven't worked.
Alexandroupoli, EvrosAges 18–95 - NCT06640309RecruitingPhase 2
Nicotinamide for rheumatoid arthritis: a clinical trial
This trial tests if taking a vitamin B3 supplement (nicotinamide) can improve outcomes for people with rheumatoid arthritis. Researchers want to see if adding this over-the-counter vitamin to your usual arthritis medicines helps reduce disease activity.
CairoAges 18–65
Common questions
- Are there clinical trials studying Drug?
- Yes. Clin2 currently lists 1,302 recruiting studies that include Drug, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Drug trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Drug an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Drug or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.